Endocrinology, Vol 133, 1347-1351, Copyright © 1993 by Endocrine Society

ARTICLES

Phorbol ester tumor promoters regulate insulin-like growth factor- binding protein-4 proteolysis

CA Conover, JT Clarkson and LK Bale
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.

Cultured human fibroblasts secrete a specific protease that alters extracellular insulin-like growth factor-binding protein-4 (IGFBP-4) structure and function. This enzyme appears to be secreted in a latent form and requires IGFs for activation. To study regulation of the IGFBP- 4 protease, we treated normal adult human fibroblasts with various hormones and growth regulatory factors, and collected the human fibroblast-conditioned medium (HFCM) for analysis of IGFBP-4 protease activity. The IGFBP-4 protease assay involved incubation of 50 microliters HFCM with or without 5 nM IGF-II for 6 h at 37 C under cell- free conditions; IGF-activated IGFBP-4 hydrolysis was assessed by Western ligand blotting. In HFCM from cells treated with vehicle, GH, insulin, epidermal growth factor, steroid hormones, or forskolin, IGF- II induced the select loss of detectable IGFBP-4 during the assay. In contrast, IGFBP-4 levels were maintained when HFCM from cells treated with phorbol ester tumor promoters was incubated with IGF-II under cell- free conditions. Hydrolysis of [125I]IGFBP-4 to 18,000 and 14,000 mol wt fragments also was prevented in HFCM from cells treated with phorbol esters. Phorbol esters had no effect on endogenous or exogenous IGFBP-4 proteolysis when added directly to HFCM during the assay, however. Treatment of cells with actinomycin-D or cycloheximide could prevent a phorbol ester-induced block of IGF-dependent IGFBP-4 proteolysis. These data suggest that phorbol ester tumor promoters stimulate human fibroblasts to produce and secrete an inhibitor of the IGFBP-4 proteolytic reaction. Alterations in IGFBP-4 protease activity could affect local IGF action through regulation of IGFBP-4 availability.

This article has been cited by other articles:

				B.-K. Chen, M. T. Overgaard, L. K. Bale, Z. T. Resch, M. Christiansen, C. Oxvig, and C. A. Conover Molecular Regulation of the IGF-Binding Protein-4 Protease System in Human Fibroblasts: Identification of a Novel Inducible Inhibitor Endocrinology, April 1, 2002; 143(4): 1199 - 1205. [Abstract] [Full Text] [PDF]

				A. Anwar, A. A. Zahid, L. Phillips, and P. Delafontaine Insulin-Like Growth Factor Binding Protein-4 Expression Is Decreased by Angiotensin II and Thrombin in Rat Aortic Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 370 - 376. [Abstract] [Full Text] [PDF]

				W. A. Price Peptide Growth Factors Regulate Insulin-Like Growth Factor Binding Protein Production by Fetal Rat Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 332 - 341. [Abstract] [Full Text]

				T. A. Jacot and D. R. Clemmons Effect of Glucose on Insulin-Like Growth Factor Binding Protein-4 Proteolysis Endocrinology, January 1, 1998; 139(1): 44 - 50. [Abstract] [Full Text] [PDF]

				J. L. Fowlkes, K. M. Thrailkill, C. George-Nascimento, C. K. Rosenberg, and D. M. Serra Heparin-Binding, Highly Basic Regions within the Thyroglobulin Type-1 Repeat of Insulin-Like Growth Factor (IGF)-Binding Proteins (IGFBPs) -3, -5, and -6 Inhibit IGFBP-4 Degradation Endocrinology, June 1, 1997; 138(6): 2280 - 2285. [Abstract] [Full Text] [PDF]

				J. L. Fowlkes, D. M. Serra, C. K. Rosenberg, and K. M. Thrailkill Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) Functions as an IGF-reversible Inhibitor of IGFBP-4 Proteolysis J. Biol. Chem., November 17, 1995; 270(46): 27481 - 27488. [Abstract] [Full Text] [PDF]

				C. A. Conover, S. K. Durham, Jür. Zapf, F. R. Masiarz, and M. C. Kiefer Cleavage Analysis of Insulin-like Growth Factor (IGF)-dependent IGF-binding Protein-4 Proteolysis and Expression of Protease-resistant IGF-binding Protein-4 Mutants J. Biol. Chem., March 3, 1995; 270(9): 4395 - 4400. [Abstract] [Full Text] [PDF]